A Study Assessing GW870086's Potential to Cause Skin Thinning
Status:
Completed
Trial end date:
2011-07-07
Target enrollment:
Participant gender:
Summary
This study is a randomised, double-blind, placebo-controlled study of topical GW870086 to
explore the potential for skin thinning in healthy adult volunteers after 42±2 days of
treatment. Twenty (20) healthy volunteers will be randomised to receive placebo and GW870086
2% cream, they will also receive either of the following treatments: GW870086 0.2% cream, or
clobetasol propionate 0.05% cream.